News | May 27, 2021
Sun Pharma Q4 FY21 net profit up 124%
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
The company plans to enter the EU markets in FY22
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
The company will be requesting a Compulsory License based on emergency use and in light of the grave and serious public health emergency across India due to the Pandemic
New agreement for three further production lines at Lonza’s site in Visp, Switzerland
Port chairpersons have been asked to personally supervise logistic operations to ensure unhindered movement of such consignments for berthing of such vessel on top priority in the port
New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space
The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions
Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power
Subscribe To Our Newsletter & Stay Updated
